COVID-19 Antibody Therapy
The FDA approved an Emergency Use Authorization for bamlanivimab (BAM) to treat COVID-19 in high risk patients. Eli Lilly released new study results that indicate the antibody therapy reduced the risk to nursing home residents. These facilities account for 40% of all COVID-related deaths in the United States. The study showed that residents given bamlanivimab saw
Recent Comments